甲基乙二醛双（脒腙）：一种对急性髓细胞白血病有效的新型药物。 - Suppr

Suppr

超能文献

Methylglyoxal bis (guanylhydrazone): a new agent active against acute myelocytic leukemia.

作者信息

FREIREICH E J, FREI E, KARON M

出版信息

Cancer Chemother Rep. 1962 Feb;16:183-6.

PMID:13894981

Abstract

摘要

相似文献

Methylglyoxal bis (guanylhydrazone): a new agent active against acute myelocytic leukemia.

Cancer Chemother Rep. 1962 Feb;16:183-6.

Hypoglycemic effects of methylglyoxal bis (guanylhydrazone) in animals and man.

Cancer Chemother Rep. 1962 Feb;16:177-81.

Clinical experience with methylglyoxal bis (guanylhydrazone) dihydrochloride: a new agent with clinical activity in acute myelocytic leukemia and the lymphomas.

Cancer Chemother Rep. 1963 Mar;27:15-26.

STUDIES ON METHYLGLYOXAL BIS(GUANYLHYDRAZONE) ANALOGS. I. HOMOLOGS OF METHYLGLYOXAL BIS(GUANYLHYDRAZONE).

J Med Chem. 1963 May;6:283-8. doi: 10.1021/jm00339a014.

COMBINATION OF METHYLGLYOXAL BIS(GUANYLHYDRAZONE) (NSC-32946)AND 6-MERCAPTOPURINE (NSC-755) IN ACUTE GRANULOCYTIC LEUKEMIA.

Cancer Chemother Rep. 1965 Apr;45:69-73.

Initial clinical study of parenteral methylglyoxal bis(guanylhydrazone) diacetate.

Cancer Chemother Rep. 1961 Apr;11:81-6.

METHYLGLYOXAL BIS(GUANYLHYDRAZONE), NSC-32946, 1 IN THE TREATMENT OF ACUTE MYELOBLASTIC AND MONOBLASTIC LEUKEMIA IN ADULTS.

Cancer Chemother Rep. 1964 Mar;36:63-71.

[PRELIMINARY RESULTS OF THE ASSOCIATION OF METHYLGLYOXAL-BIS(GUANYLHYDRAZONE AND 6-MERCAPTOPURINE IN THE TREATMENT OF ACUTE LEUKEMIAS OF THE GRANULOCYTIC SERIES].

Presse Med (1893). 1964;72:807-9.

The antileukemic effectiveness of methylglyoxal bis(guanylhydrazone) in mice. Studies of cross-resistance and combination chemotherapy.

Cancer Chemother Rep. 1963 Apr;28:1-4.

Antibacterial agents. Some new guanylhydrazone derivatives.

J Med Pharm Chem. 1961 Jul 1;4:177-82. doi: 10.1021/jm50017a013.

引用本文的文献

METHYL- G.A.G. AND LEUKAEMIA.

Br Med J. 1964 Sep 12;2(5410):647.

Pharmacokinetic study of methyl glyoxal-bis-guanylhydrazone (methyl-GAG).

Invest New Drugs. 1983;1(3):219-24. doi: 10.1007/BF00208893.

Phase II evaluation of MGBG in non-small cell carcinoma of the lung. A Southwest Oncology Group study.

Invest New Drugs. 1983;1(1):89-93. doi: 10.1007/BF00180196.

Disposition of methylglyoxal bis(guanylhydrazone) (MGBG, NSC-32946) in man.

Cancer Chemother Pharmacol. 1981;7(1):31-5. doi: 10.1007/BF00258210.

Acute leukaemia--the current therapeutic position.

Proc R Soc Med. 1968 May;61(5):471-6. doi: 10.1177/003591576806100525.

Cisplatin, VP-16-213 and MGBG (methylglyoxal bis guanylhydrazone) combination chemotherapy in refractory lymphoma, a phase II study.

Invest New Drugs. 1988 Sep;6(3):231-7. doi: 10.1007/BF00175405.

Treatment of acute myeloid leukemia and blastic phase of chronic myeloid leukemia with combined eflornithine (alpha difluoromethylornithine) and methylglyoxal-bis-guanyl hydrazone (methyl-GAG).

Cancer Chemother Pharmacol. 1987;20(4):344-8. doi: 10.1007/BF00262590.

Combined therapy of polyamine antimetabolites and antitumor drugs for human gastric cancer xenotransplanted into nude mice.

Jpn J Surg. 1986 Mar;16(2):133-9. doi: 10.1007/BF02471083.

Phase I study of methylacetylenic putrescine, an inhibitor of polyamine biosynthesis.

Cancer Chemother Pharmacol. 1989;23(6):348-52. doi: 10.1007/BF00435834.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验